Worth reading
60In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
613
¥ millions (total, approximate amount)Wording
Conditional
How definitive the wording is.This transaction
Acquisition of an Equity Interest in 有限会社アカサカ歯材社 (Making It a Subsidiary)CounterpartyAkasaka Hiroyuki (赤坂 博之), Akasaka Masanori (赤坂 昌則), Akasaka Takeo (赤坂 武夫)
Disclosing companyGENOVA,Inc.
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
TimelineThe spacing between the points is proportional to the actual number of days.
Target company
Sale of dental materials
Location Kawagoe City, Saitama PrefectureShare capital ¥9 millionDate of incorporation 19 May 1980
Net Sales¥5,760.388 million (fiscal year ended 20 April 2025)
Operating profit¥24.361 million (fiscal year ended 20 April 2025)
Net income for the current fiscal year¥20.297 million (fiscal year ended 20 April 2025)
Net assets¥168.741 million (fiscal year ended 20 April 2025)
Consideration and expenses
Acquisition price¥600 million (Note)
Expenses other than the acquisition price¥13 million (approximate amount)
Type of ConsiderationCash (¥600 million as the acquisition price)
Impact on Business Performance
The impact of this acquisition of an equity interest on the Company's results of operations and financial condition for the fiscal year ending March 2026 is currently under review. The Company will promptly announce any matters requiring disclosure in the future.
Procedures and assumptions
Valuation methodologyDetermined based on consideration of a shareholder value assessment, financial due diligence, legal due diligence and other analyses conducted by external institutions, in accordance with the agreement reached through negotiations with the sellers
Management structure after acquisition有限会社アカサカ歯材社 is scheduled to become a consolidated subsidiary of the Company from the second quarter of the fiscal year ending March 2027. Changes to the trade name, representative, and treatment of employees: not disclosed
| Item | Details |
|---|---|
| Transaction name | Acquisition of an Equity Interest in 有限会社アカサカ歯材社 (Making It a Subsidiary) |
| Counterparty name | Akasaka Hiroyuki (赤坂 博之), Akasaka Masanori (赤坂 昌則), Akasaka Takeo (赤坂 武夫) |
| Name of the Subject Company | 有限会社アカサカ歯材社 |
| Business Description of the Subject Company | Sale of dental materials |
| Location of the Subject Company | Kawagoe City, Saitama Prefecture |
| Capital Stock of the Subject Company | ¥9 million |
| Date of Establishment of the Subject Company | 19 May 1980 |
| Net Sales of the Subject Company | ¥5,760.388 million (fiscal year ended 20 April 2025) |
| Operating Profit of the Subject Company | ¥24.361 million (fiscal year ended 20 April 2025) |
| Net Income of the Subject Company | ¥20.297 million (fiscal year ended 20 April 2025) |
| Net Assets of the Subject Company | ¥168.741 million (fiscal year ended 20 April 2025) |
| Acquisition price | ¥600 million (Note) |
| Expenses other than the acquisition price | ¥13 million (approximate amount) |
| Type of Consideration | Cash (¥600 million as the acquisition price) |
| Number of shares acquired | 9,000 shares (number of voting rights: 9,000) |
| Voting rights ownership percentage | Before －％ → after 100％ |
| Impact on Business Performance | The impact of this acquisition of an equity interest on the Company's results of operations and financial condition for the fiscal year ending March 2026 is currently under review. The Company will promptly announce any matters requiring disclosure in the future. |
| Date of board resolution | 1 April 2026 |
| Contract Date | 1 April 2026 |
| Execution Date / Effective Date | 21 April 2026 (scheduled) |
| Valuation methodology | Determined based on consideration of a shareholder value assessment, financial due diligence, legal due diligence and other analyses conducted by external institutions, in accordance with the agreement reached through negotiations with the sellers |
| Management structure after acquisition | 有限会社アカサカ歯材社 is scheduled to become a consolidated subsidiary of the Company from the second quarter of the fiscal year ending March 2027. Changes to the trade name, representative, and treatment of employees: not disclosed |
Items this document does not state (10)
Merger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Independent valuation institutionSpecial CommitteeConditions Precedent to Execution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The acquisition is intended to integrate ASANO's dental distribution network with 有限会社アカサカ歯材社's specialized logistics network in the dental laboratory sector, thereby building a supply chain covering the entire process from dental clinics to dental laboratories. The transaction is also expected to stabilize and improve the efficiency of dental healthcare infrastructure, generate synergies with other businesses, expand the business base, and improve management efficiency.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.